SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-018480
Filing Date
2023-05-08
Accepted
2023-05-08 08:28:43
Documents
50
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q maia-20230331.htm   iXBRL 10-Q 1572650
2 EX-31.1 maia-ex31_1.htm EX-31 21461
3 EX-31.2 maia-ex31_2.htm EX-31 21625
4 EX-32.1 maia-ex32_1.htm EX-32 13074
5 EX-32.2 maia-ex32_2.htm EX-32 14466
  Complete submission text file 0000950170-23-018480.txt   5946658

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT maia-20230331_def.xml EX-101.DEF 141059
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT maia-20230331.xsd EX-101.SCH 41141
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT maia-20230331_cal.xml EX-101.CAL 28258
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT maia-20230331_lab.xml EX-101.LAB 362966
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT maia-20230331_pre.xml EX-101.PRE 257425
44 EXTRACTED XBRL INSTANCE DOCUMENT maia-20230331_htm.xml XML 955797
Mailing Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606
Business Address 444 WEST LAKE STREET, SUITE 1700 CHICAGO IL 60606 312-416-8592
MAIA Biotechnology, Inc. (Filer) CIK: 0001878313 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41455 | Film No.: 23895957
SIC: 2834 Pharmaceutical Preparations